Results 261 to 270 of about 138,145 (310)

Diversifying the triquinazine scaffold of a Janus kinase inhibitor. [PDF]

open access: yesRSC Med Chem
Mulliri K   +5 more
europepmc   +1 more source

Heterobimetallic Pt(II) Complexes Supported by 1,8‐Naphthyridine Ligands Confirm the Rotation of C6F5 Groups about the Pt−C Bond

open access: yesZeitschrift für anorganische und allgemeine Chemie, Volume 652, Issue 1, January 6, 2026.
You Spin Me Round. The ligand 1,8‐naphthyridine is able to stabilize heterobimetallic complexes containing Pt(II)→M (M = Ag, Cu) donor–acceptor bonds, in which the rotation of the C6F5 ligands in solution can be stopped at low temperature. The ligand 1,8‐naphthyridine (napy) exhibits a rich coordination chemistry arising from the disposition of its two
Alberto Pérez‐Bitrián   +4 more
wiley   +1 more source

Defluoroalkylation of Trifluoromethane with Organolithium Reagents: Mechanism and Synthesis of Fluoroalkenes

open access: yesAngewandte Chemie, Volume 138, Issue 1, 2 January 2026.
We report a rare example of the transformation of HCF3 into a fluoroalkene functional group through defluoroalkylation. We rationalise product formation through DFT calculations, scale‐up the synthesis through continuous flow methods, and show that a fluoroalkene reagent derived from HCF3 is a competent nucleophile for the fluoroethenylation of a range
Hodan R. Warsame   +4 more
wiley   +1 more source

Synthesis of Enantiopure [3]Cyclorubicenes

open access: yesAngewandte Chemie, Volume 138, Issue 1, 2 January 2026.
Herein, we present a high yielding synthesis of enantiopure [3]cyclorubicene, which is a potential precursor for a Haeckelite nanotube. This macrocycle was studied for its electronic and chiroptical properties and exhibits one of the highest dissymmetry values reported for a nanohoop.
Moritz P. Schuldt   +2 more
wiley   +1 more source

Schweinfurthins and their analogues are highly selective cellular probes for oxysterol-binding protein (OSBP). [PDF]

open access: yesRSC Med Chem
Depta L   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy